Skip to main content
MRMD
OTC Life Sciences

MariMed Q3 Revenue Hits $44.2M, Adjusted EBITDA $4.7M as Net Loss Widens

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.075
Mkt Cap
$30.079M
52W Low
$0.045
52W High
$0.16
52W Position info
66% above low
Off High info
53% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

MRMD sits 66% above its 52-week low of $0.045 on elevated volume (1.9× avg).

Summary

MariMed posted record Q3 revenue of $44.2M, up from the record $41.9M in Q2, with adjusted EBITDA of $4.7M and an 11% adjusted EBITDA margin. Gross margin came in at 39% (40% adjusted), but the company still lost $3.5M on a net basis and $2.3M adjusted — a wider loss than Q2's $3.6M net loss on a smaller revenue base. The top line is growing, but profitability remains elusive at a micro-cap scale. This is the first hard look at Q3 numbers ahead of any formal release detail, and the quarter also brought positive operating cash flow. The reverse split approved October 29 (1-for-50 to 1-for-100) is still pending execution and will reset the share count and price.

At the time of this announcement, MRMD was trading at $0.07 on OTC in the Life Sciences sector, with a market capitalization of approximately $30.1M. The 52-week trading range was $0.05 to $0.16. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MRMD - Latest Insights

MRMD
Oct 29, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.053
Real-time Price: $0.0745 info
Change: +$0.0215 (+41%) info
Market Cap: $30.079M info
MRMD
Sep 22, 2026, 4:42 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.0732
Real-time Price: $0.0745 info
Change: +$0.0013 (+2%) info
Market Cap: $30.079M info
MRMD
Sep 11, 2026, 4:06 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.0788
Real-time Price: $0.0745 info
Change: -$0.0043 (-5%) info
Market Cap: $30.079M info
MRMD
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.065
Real-time Price: $0.0745 info
Change: +$0.0095 (+15%) info
Market Cap: $30.079M info
MRMD
Aug 12, 2026, 5:11 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.06405
Real-time Price: $0.0745 info
Change: +$0.01045 (+16%) info
Market Cap: $30.079M info